[{"Assets_0_Q1_USD":88180000.0,"EarningsPerShareBasic_1_Q1_USD":-0.32,"EarningsPerShareDiluted_1_Q1_USD":-0.32,"NetIncomeLoss_1_Q1_USD":-7098000.0,"StockholdersEquity_0_Q1_USD":-220305000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":22350436.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":22350436.0,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170510"}]